Protelos Articles

Benefits of Diane 35 and generics outweigh risks in specific patient group, says EMA unit; other actions

17 May 2013

EMA Committee calls for curbs on Protelos/Osseor, tetrazepam suspension

12 April 2013

EMA backs Protelos and Osseor, but with warnings

19 March 2012

EMA says risk-benefit of ARBs positive; acts on Advagraf and Protelos/Osseor

21 October 2011

UK’s NICE backs Abilify for teenagers; sticks with guidance on Servier’s Protelos

27 January 2011

Servier’s Protelos builds stronger bone compared to bisphosphonates, study shows

22 June 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end